These results indicate that KRAS-mutant NSCLC with co-inactivation of LKB1 and KEAP1 enhanced Gln dependence compared to KRAS-mutant NSCLC with LKB1 or KEAP1 inactivation. The gene discussed is STK11; the disease is non-small cell lung carcinoma.